Brain scans that trace nerve paths may help aim radiation
Original title: White matter pathlength maps from diffusion-weighted MRI tractography for radiotherapy target planning in glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
Scans and plans were compared in 13 people, but no one was treated this way.
The short version
A small study used special brain scans to plan radiation around the paths where tumors spread.
What was studied. Doctors studied thirteen people with glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary after surgery. Each had a special MRI that maps the brain's nerve fiber paths. The team used those maps to draw the radiation target. They compared it to the usual target shape.
What they found. The map based target spread along nerve paths instead of an even ball shape. It also stayed inside natural borders in the brain. These targets were 67 cc smaller, about 19% less than the usual ones. The tumor came back inside the usual target in 10 of 13 people. With the map based target, it came back inside in 12 of 13 people.
What this means, and what it doesn't
What it could mean: Radiation might one day be aimed with more care. It could cover risky areas while sparing more healthy brain. This is not how radiation is planned today.
What it doesn't mean: This was a small early study that looked back at scans. No one was actually treated with the new target shape. It does not show that people live longer or have fewer side effects. It is not a cure, and it is not something you can ask for at a clinic now.
Source: PubMed, September 25, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.